CD274 and neoplasm: Combined with the previously mentioned results of tumor growth inhibition in mice, we speculate that 4T1 cells may have obvious T-cell exhaustion, making them insensitive to anti-PD-L1 treatment alone; therefore, the application of anti-PD-L1 therapy alone still will not have a lasting inhibitory effect on 4T1 tumors (37, 38).